SEC Form 4 · accession 0000899866-18-000093
ALEXION PHARMACEUTICALS, INC. · ALXN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Deborah Dunsire
Director
Period of report
May 9, 2018
Accepted (ET)
May 11, 2018 · 4:13 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000899866
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock, par value $.0001 per shareF1 | May 9, 2018 | A | 2,174 | $0.00 | A | 4,259 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Award of Restricted Stock Units under the 2017 Incentive Plan. Award vests on the anniversary of the grant date.